Show simple item record

dc.contributor.authorLiu, Yi-Hsia
dc.contributor.authorMoelzer, Christine
dc.contributor.authorMakinen, Kimmo
dc.contributor.authorKamoi, Koju
dc.contributor.authorCorbett, Clare L.C.
dc.contributor.authorKlaska, Izabela
dc.contributor.authorReid, Delyth
dc.contributor.authorWilson, Heather M.
dc.contributor.authorKuffova, Lucia
dc.contributor.authorCornall, Richard J.
dc.contributor.authorForrester, John V.
dc.date.accessioned2020-09-07T11:20:01Z
dc.date.available2020-09-07T11:20:01Z
dc.date.issued2020-09-04
dc.identifier.citationLiu , Y-H , Moelzer , C , Makinen , K , Kamoi , K , Corbett , C L C , Klaska , I , Reid , D , Wilson , H M , Kuffova , L , Cornall , R J & Forrester , J V 2020 , ' Treatment with FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis ' , Frontiers in Immunology , vol. 11 , 2071 , pp. 1-17 . https://doi.org/10.3389/fimmu.2020.02071en
dc.identifier.issn1664-3224
dc.identifier.otherPURE: 173200195
dc.identifier.otherPURE UUID: 09498175-7352-43e7-9254-1ea8f88f8bc4
dc.identifier.otherORCID: /0000-0002-8015-7774/work/79062842
dc.identifier.otherScopus: 85091212762
dc.identifier.otherWOS: 000573606100001
dc.identifier.urihttps://hdl.handle.net/2164/15091
dc.descriptionFUNDING: This work was funded by Fight for Sight, The Eye Charity (CSO project grant award: 3031-3032), and The Development Trust of the University of Aberdeen (Saving Sight in Grampian) (Grant codes: RG-12663 and RG-14251). ACKNOWLEDGMENTS: We thank the Iain Fraser Flow Cytometry core facility, and the Microscopy and Histology core facility of the University of Aberdeen.en
dc.format.extent17
dc.language.isoeng
dc.relation.ispartofFrontiers in Immunologyen
dc.rightsCopyright © 2020 Liu, Mölzer, Makinen, Kamoi, Corbett, Klaska, Reid, Wilson, Kuffová, Cornall and Forrester. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. https://creativecommons.org/licenses/by/4.0/en
dc.subjectAutoimmune uveitisen
dc.subjectcell therapyen
dc.subjectAdoptive Transferen
dc.subjecthen-egg lysozymeen
dc.subjectT cell anergyen
dc.subjectanti-uveitogenicen
dc.subjectautoimmune uveitisen
dc.subjectadoptive transferen
dc.subjectHOMEOSTASISen
dc.subjectSELFen
dc.subjectEXPERIMENTAL AUTOIMMUNE UVEORETINITISen
dc.subjectRESPONSESen
dc.subjectTHERAPYen
dc.subjectINFLAMMATIONen
dc.subjectDISEASEen
dc.subjectMICEen
dc.subjectEXPRESSIONen
dc.subjectANTIGENen
dc.subjectR Medicineen
dc.subjectImmunology and Allergyen
dc.subjectImmunologyen
dc.subjectChief Scientist Office (CSO)en
dc.subject3031-3032en
dc.subjectOtheren
dc.subjectRG-12663en
dc.subjectRG-14251en
dc.subjectSupplementary data availableen
dc.subject.lccRen
dc.titleTreatment with FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.3389/fimmu.2020.02071
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85091212762&partnerID=8YFLogxKen
dc.identifier.urlhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.02071/full#supplementary-materialen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record